[ad_1] Attunity (NASDAQ:ATTU) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, October 9th. The firm currently has a $18.00 price …
Read More »KBC Grp NV/ADR (OTCMKTS:KBCSY) Upgraded by Zacks Investment Research to “Buy”
[ad_1] Zacks Investment Research upgraded shares of KBC Grp NV/ADR (OTCMKTS:KBCSY) from a hold rating to a buy rating in a research report report published on Thursday, September 27th. They currently have …
Read More »Danaos (DAC) Lowered by Zacks Investment Research Stock Rating
[ad_1] Danaos (NYSE: DAC) was downgraded by Zacks Investment Research from a "strong-buy" rating to a "hold" rating in a research report issued to clients and investors on Thursday. According to Zacks, …
Read More »Magic Software Enterprises (MGIC) Downgraded by Zacks Investment Research to Hold
[ad_1] Magic Software Enterprises (NASDAQ:MGIC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday, October 10th. According to Zacks, “Magic Software …
Read More »Eloxx Pharmaceuticals (ELOX) demoted by Zacks Investment Research
[ad_1]
Read More »Zacks: CELLECT BIOTECH / S (APOP) receives the average rating of "Strong Buy" analysts
[ad_1] The shares of CELLECT BIOTECH / S (NASDAQ: APOP) received an average broker rating of 1.00 (Strong Purchase) of According to a stock research badyst, the 39; equity research badyst felt …
Read More »Zacks: Cyren Ltd (CYRN) Based on consensus target price of $ 3.00 per analyst
[ad_1]
Read More »Israel Chemicals (ICL) demoted by Zacks Investment Research to "Hold"
[ad_1]
Read More »Zacks Investment Research demotes Mediwound (MDWD) to sell
[ad_1] <img src = "https://www.marketbeat.com/logos/mediwound-ltd-logo.jpg" alt = "Mediwound (NASDAQ: MDWD) was downgraded by Zacks Investment Research from a note of "hold" to a note of "sell" in According to Zacks, "MediWound Ltd. …
Read More »Zacks Investment Research lowers the company Monsanto (MON) to hold – BharataPress
[ad_1] According to Zacks, "In the last three months, Monsanto shares have outperformed the Zacks agricultural products and products industry.The company announced better than expected results for the third quarter of the …
Read More »